Comprehensive Characterization of the Recombinant Catalytic Subunit of cAMP-Dependent Protein Kinase by Top-Down Mass Spectrometry.

Reversible phosphorylation plays critical roles in cell growth, division, and signal transduction. Kinases which catalyze the transfer of γ-phosphate groups of nucleotide triphosphates to their substrates are central to the regulation of protein phosphorylation and are therefore important therapeutic targets. Top-down mass spectrometry (MS) presents unique opportunities to study protein kinases owing to its capabilities in comprehensive characterization of proteoforms that arise from alternative splicing, sequence variations, and post-translational modifications. Here, for the first time, we developed a top-down MS method to characterize the catalytic subunit (C-subunit) of an important kinase, cAMP-dependent protein kinase (PKA). The recombinant PKA C-subunit was expressed in Escherichia coli and successfully purified via his-tag affinity purification. By intact mass analysis with high resolution and high accuracy, four different proteoforms of the affinity-purified PKA C-subunit were detected, and the most abundant proteoform was found containing seven phosphorylations with the removal of N-terminal methionine. Subsequently, the seven phosphorylation sites of the most abundant PKA C-subunit proteoform were characterized simultaneously using tandem MS methods. Four sites were unambiguously identified as Ser10, Ser11, Ser18, and Ser30, and the remaining phosphorylation sites were localized to Ser2/Ser3, Ser358/Thr368, and Thr[215-224]Tyr in the PKA C-subunit sequence with a 20mer 6xHis-tag added at the N-terminus. Interestingly, four of these seven phosphorylation sites were located at the 6xHis-tag. Furthermore, we have performed dephosphorylation reaction by Lambda protein phosphatase and showed that all phosphorylations of the recombinant PKA C-subunit phosphoproteoforms were removed by this phosphatase.

[1]  Zhijie Wu,et al.  Reproducible large-scale synthesis of surface silanized nanoparticles as an enabling nanoproteomics platform: Enrichment of the human heart phosphoproteome , 2019, Nano Research.

[2]  J. Lebbink Faculty Opinions recommendation of Protein structure. Direct observation of structure-function relationship in a nucleic acid-processing enzyme. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[3]  Chad R. Weisbrod,et al.  Implementation of Fragment Ion Protection (FIP) during Ultraviolet Photodissociation (UVPD) Mass Spectrometry. , 2018, Analytical chemistry.

[4]  Avi Ma'ayan,et al.  Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks , 2018, Science Signaling.

[5]  Ziqing Lin,et al.  Impact of Phosphorylation on the Mass Spectrometry Quantification of Intact Phosphoproteins. , 2018, Analytical chemistry.

[6]  N. Gray,et al.  Kinase inhibitors: the road ahead , 2018, Nature Reviews Drug Discovery.

[7]  Lloyd M. Smith,et al.  Proteoforms as the next proteomics currency , 2018, Science.

[8]  Lloyd M. Smith,et al.  How many human proteoforms are there? , 2018, Nature chemical biology.

[9]  Ying Ge,et al.  Top-Down Proteomics: Ready for Prime Time? , 2018, Analytical chemistry.

[10]  Ying Ge,et al.  Coupling functionalized cobalt ferrite nanoparticle enrichment with online LC/MS/MS for top-down phosphoproteomics† †Electronic supplementary information (ESI) available: Material and methods, characterization of the NPs, and top-down MS. See DOI: 10.1039/c6sc05435h Click here for additional data fi , 2017, Chemical science.

[11]  Jian-Kang Zhu,et al.  Phosphoproteins in extracellular vesicles as candidate markers for breast cancer , 2017, Proceedings of the National Academy of Sciences.

[12]  Ying Ge,et al.  Top-down Proteomics: Technology Advancements and Applications to Heart Diseases , 2016, Expert review of proteomics.

[13]  N. Kelleher,et al.  Progress in Top-Down Proteomics and the Analysis of Proteoforms. , 2016, Annual review of analytical chemistry.

[14]  Pier Federico Gherardini,et al.  Deep Proteomics of Breast Cancer Cells Reveals that Metformin Rewires Signaling Networks Away from a Pro-growth State. , 2016, Cell systems.

[15]  Ying Peng,et al.  MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics* , 2015, Molecular & Cellular Proteomics.

[16]  Ying Ge,et al.  Effective top-down LC/MS+ method for assessing actin isoforms as a potential cardiac disease marker. , 2015, Analytical chemistry.

[17]  W. I. Mohamed,et al.  A bimodular nuclear localization signal assembled via an extended double-stranded RNA-binding domain acts as an RNA-sensing signal for transportin 1 , 2014, Proceedings of the National Academy of Sciences.

[18]  Terry K. Smith,et al.  Coupled Enzyme Activity and Thermal Shift Screening of the Maybridge Rule of 3 Fragment Library Against Trypanosoma brucei Choline Kinase; A Genetically Validated Drug Target , 2013 .

[19]  R. Roskoski ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[20]  Ying Ge,et al.  Augmented Phosphorylation of Cardiac Troponin I in Hypertensive Heart Failure* , 2011, The Journal of Biological Chemistry.

[21]  Richard D. LeDuc,et al.  Mapping Intact Protein Isoforms in Discovery Mode Using Top Down Proteomics , 2011, Nature.

[22]  Ying Ge,et al.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. , 2011, Journal of proteome research.

[23]  D. Waugh An overview of enzymatic reagents for the removal of affinity tags , 2011, Protein Expression and Purification.

[24]  M. Cyert,et al.  Cracking the Phosphatase Code: Docking Interactions Determine Substrate Specificity , 2009, Science Signaling.

[25]  Virgil L. Woods,et al.  Global Consequences of Activation Loop Phosphorylation on Protein Kinase A* , 2009, The Journal of Biological Chemistry.

[26]  Ying Ge,et al.  Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state , 2009, Proceedings of the National Academy of Sciences.

[27]  W. Noble,et al.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.

[28]  N. Kelleher,et al.  Decoding protein modifications using top-down mass spectrometry , 2007, Nature Methods.

[29]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[30]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[31]  C. Wheeler-Jones,et al.  Cell signalling in the cardiovascular system: an overview , 2005, Heart.

[32]  K. Chatterjee Neurohormonal activation in congestive heart failure and the role of vasopressin. , 2005, The American journal of cardiology.

[33]  L. Iakoucheva,et al.  The importance of intrinsic disorder for protein phosphorylation. , 2004, Nucleic acids research.

[34]  Natalie G. Ahn,et al.  Identification of Novel Phosphorylation Sites on Xenopus laevis Aurora A and Analysis of Phosphopeptide Enrichment by Immobilized Metal-affinity Chromatography * , 2003, Molecular & Cellular Proteomics.

[35]  John D. Scott,et al.  Targeting of Protein Kinase A by Muscle A Kinase-anchoring Protein (mAKAP) Regulates Phosphorylation and Function of the Skeletal Muscle Ryanodine Receptor* , 2003, Journal of Biological Chemistry.

[36]  A. Clerk,et al.  Kinases as therapeutic targets for heart failure , 2003, Nature Reviews Drug Discovery.

[37]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[38]  John D. Scott,et al.  Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo , 2002, Nature Cell Biology.

[39]  Neil L. Kelleher,et al.  Informatics and multiplexing of intact protein identification in bacteria and the archaea , 2001, Nature Biotechnology.

[40]  A. Tholey,et al.  Influence of myristoylation, phosphorylation, and deamidation on the structural behavior of the N-terminus of the catalytic subunit of cAMP-dependent protein kinase. , 2001, Biochemistry.

[41]  F. McLafferty,et al.  Electron capture dissociation for structural characterization of multiply charged protein cations. , 2000, Analytical chemistry.

[42]  S. Taylor,et al.  Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli. , 1997, Protein engineering.

[43]  N. Xuong,et al.  Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. , 1997, Biochemistry.

[44]  T. Hunter,et al.  Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.

[45]  S. Taylor,et al.  Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase. , 1993, The Journal of biological chemistry.

[46]  S. Taylor,et al.  Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli: multiple isozymes reflect different phosphorylation states. , 1993, Protein engineering.

[47]  S. Taylor,et al.  Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase. , 1992, The Journal of biological chemistry.

[48]  P. Dessen,et al.  Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[50]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[51]  J. Zheng,et al.  Structural framework for the protein kinase family. , 1992, Annual review of cell biology.

[52]  S. Shall Protein Structure , 1970, Nature.